Crystal structure and physical properties of the two stannides EuPdSn2 and YbPdSn2.

We report on synthesis, crystal structure and physical properties of the isotypic compounds YbPdSn2 and EuPdSn2 crystallizing in the MgCuAl2-type structure. In both stannides a divalent state of respective rare earth element was found from analysis of the magnetic susceptibilities. Whereas in YbPdSn2 only weak paramagnetic behaviour is observed, in EuPdSn2 a long-range magnetic phase transition occurs at 12.5 K with complex magnetic behaviour evidenced by magnetic susceptibity and specific heat measurements. Under the influence of magnetic field, the magnetic behaviour was found to evolve from an antiferromagnetic to a ferromagnetic state as a consequence of a re-arrangement of magnetic moments.

Competition between ferromagnetism and frustrated antiferromagnetism in quasi 2D Ce2.15(Pd1-x Ag x )1.95In0.9 alloys.

Low temperature thermal and magnetic measurements performed on ferro-magneticl (FM) alloys of composition Ce2.15(Pd1-x Ag x )1.95In0.9 are presented. Pd substitution by Ag depresses [Formula: see text] from 4.1 K down to 1.1 K for x = 0.5, which is related to the increase of band electrons, with a critical concentration extrapolated to [Formula: see text]. The [Formula: see text] decrease is accompanied by a weakening of the magnetization of the FM phase. At high temperature (T > 30 K) the inverse magnetic susceptibility reveals the presence of robust magnetic moments ([Formula: see text] [Formula: see text]), whereas the low value of the Curie-Weiss temperature [Formula: see text] K excludes any relevant effect from Kondo screening. The specific heat jump at [Formula: see text] decreases accordingly, while an anomaly emerges at a fixed temperature [Formula: see text] K. This unexpected anomaly does not show any associated sign of magnetism checked by AC-susceptibility measurements. Since the total magnetic entropy (evaluated around [Formula: see text]) practically does not change with Ag concentration, the transference of degrees of freedom from the FM component to the non-magnetic T (*) anomaly is deduced. The origin of this anomaly is attributed to an arising magnetic frustration of the ground state and the consequent entropy bottleneck produced by the divergent increasing of density of excitations at low temperature.

Abordaje inusual en el tratamiento de las endofugas aórticas tipo II / Unusual approach for the treatment of a type II endoleak

Presentamos un paciente masculino de 88 años con antecedente de reparación endovascular de aneurisma aórtico y endofuga aórtica tipo II (EA2). Se consideró la cateterización directade la arteria lumbar como la alternativa para solucionar la EA2 de la endoprótesis aórtica, cuando otras alternativas (embolización transarterial) fracasaron en el control del crecimiento del aneurisma aórtico. Se decidió un abordaje translumbar mediante punción de la arteria lumbar (L4) izquierda. Previamente, se valoraron las arterias lumbares (L4) con TC abdominal en fase arterial,y así guiar el acceso bajo control fluoroscópico. La angiografía diagnóstica demostró la entrada de arterias sacra media y lumbar derecha en el saco aneurismático. La embolización transcatéter de la arteria sacra media y las arterias lumbares izquierda y derecha (L4) con microcoils de fibras de platino permitió la devascularización satisfactoria de la endofuga (AU)

This case presentation is about an 88 years-old male patient with previous endovascular aortic aneurysm repairment history and aortic endoleak type II (EL2). The direct lumbar artery catheterization was considered an alternative to solve EL2, associated with aortic endovascular prosthesis and due to an incomplete sealing or exclusion of the aneurysmal sac or a vascular segment demonstrated by imaging studies, when other treatment alternative failed (transarterial embolization) to control the aneurysm growing. Performing translumbar approach was decided by puncturing the artery lumbar (L4) left, previously the lumbar arteries (L4) were evaluated in the abdominal CT arterial phase to guide a puncture/access under flouroscopy control. Diagnostic angiogram clearly demonstrated the median sacral and right lumbar arteries inflow into the aneurysm sac. Transcatheter embolization with fibered platinum microcoils was performed of the median sacral artery and lumbar left and right arteries (L4), showing satisfactory endoleak devascularization (AU)

Unusual approach for the treatment of a type II endoleak. / Abordaje inusual en el tratamiento de las endofugas aórticas tipo II.

This case presentation is about an 88 years-old male patient with previous endovascular aortic aneurysm repairment history and aortic endoleak type II (EL2). The direct lumbar artery catheterization was considered an alternative to solve EL2, associated with aortic endovascular prosthesis and due to an incomplete sealing or exclusion of the aneurysmal sac or a vascular segment demonstrated by imaging studies, when other treatment alternative failed (transarterial embolization) to control the aneurysm growing. Performing translumbar approach was decided by puncturing the artery lumbar (L4) left, previously the lumbar arteries (L4) were evaluated in the abdominal CT arterial phase to guide a puncture/access under flouroscopy control. Diagnostic angiogram clearly demonstrated the median sacral and right lumbar arteries inflow into the aneurysm sac. Transcatheter embolization with fibered platinum microcoils was performed of the median sacral artery and lumbar left and right arteries (L4), showing satisfactory endoleak devascularization.

Randomized controlled trial of a new portable calf compression device (Venowave) for prevention of venous thrombosis in high-risk neurosurgical patients.

BACKGROUND: Patients undergoing neurosurgical procedures are at risk of venous thromboembolism (VTE), but often have contraindications for anticoagulant prophylaxis. OBJECTIVES: To assess the efficacy and tolerability of a new, lightweight, portable, battery-powered, intermittent calf compression device, Venowave, for the prevention of VTE in neurosurgical inpatients. PATIENTS/METHODS: We performed an open randomized controlled trial comparing Venowave with control for the prevention of VTE in patients undergoing neurosurgery. The primary outcome was the composite of asymptomatic deep vein thrombosis (DVT) detected by screening venography or compression ultrasound performed on day 9 (± 2 days) and symptomatic VTE. RESULTS: We randomized 75 patients to receive Venowave devices and 75 to the control group. All patients were prescribed graduated compression stockings and physiotherapy. VTE occurred in three patients randomized to Venowave and in 14 patients randomized to control (4.0% vs. 18.7%, relative risk 0.21; 95% confidence interval 0.05-0.75, P = 0.008). Similar reductions were seen for proximal DVT (2.7% vs. 8.0%) and symptomatic VTE (0% vs. 2.7%), and the results were consistent in all subgroups examined. CONCLUSIONS: Venowave devices are effective in preventing VTE in high-risk neurosurgical patients.